Related Experiment Videos
Does continuous ambulatory peritoneal dialysis induce hypercholesterolemia?
G Panarello1, G Calianno, H De Baz
1Nephrology Service, Civil Hospital, Pordenone, Italy.
Insights
Continuous ambulatory peritoneal dialysis (CAPD) is linked to higher hypercholesterolemia rates and poorer metabolic profiles compared to hemodialysis (HD). Patients on CAPD require careful selection and aggressive management of glucose intolerance and high cholesterol to prevent coronary artery disease.
Area of Science:
- Nephrology
- Cardiology
- Metabolic Disorders
Background:
- Hypercholesterolemia is a key risk factor for atherosclerosis and coronary artery disease (CAD).
- Dialysis modality may influence metabolic profiles and cardiovascular risk in patients with chronic kidney disease.
Purpose of the Study:
- To determine the prevalence of hypercholesterolemia in patients undergoing hemodialysis (HD) versus continuous ambulatory peritoneal dialysis (CAPD).
- To investigate the role of dialysis type in metabolic parameters associated with cardiovascular risk.
Main Methods:
- Cross-sectional study comparing 19 HD patients and 20 CAPD patients.
- Evaluation of anthropometric (body weight, BMI, AMA) and biochemical parameters (lipids, HbA1c, apolipoproteins).
- Hypercholesterolemia defined as cholesterol >220 mg/dL and LDL >150 mg/dL.
Main Results:
- CAPD patients exhibited higher body weight, BMI, AMA, total cholesterol, LDL, cholesterol/HDL ratio, and HbA1c compared to HD patients (p < 0.05).
- Hypercholesterolemia prevalence was significantly higher in CAPD (11/20) than in HD (3/19) patients (p < 0.05).
- A positive correlation was observed between HbA1c and cholesterol/HDL ratio in the CAPD group (r = 0.48; p < 0.05).
Conclusions:
- CAPD is associated with a higher prevalence of hypercholesterolemia and unfavorable metabolic changes.
- Careful patient selection for CAPD is crucial.
- Aggressive management of glucose intolerance and hypercholesterolemia in CAPD patients is essential to mitigate CAD risk.
Abstract:
Hypercholesterolemia has been recognized as a significant risk factor for atherosclerosis and coronary artery disease. The aim of this study was to evaluate the prevalence of hypercholesterolemia and the role, if any, of type of dialysis. In 19 hemodialysis (HD) and 20 continuous ambulatory peritoneal dialysis (CAPD) subjects, body weight, body mass index (BMI), arm muscle area (AMA), total cholesterol (C), HDL and LDL fractions, triglycerides, C/HDL ratio, glycosylated hemoglobin, and apolipoproteins AI, AII, B, CII, CIII, and E were evaluated. Hypercholesterolemia was defined as cholesterol greater than 220 mg/dL and LDL greater than 150 mg/dL. Body weight, body mass index, and arm muscle area were higher (p < 0.05) in CAPD as compared with HD; so were total cholesterol, LDL, C/HDL ratio, and glycosylated hemoglobin (Hbalc). Hypercholesterolemia prevalence was 3/19 in HD and 11/20 in CAPD (p < 0.05). A relationship between Hbalc and C/HDL ratio was found in the CAPD group (r = 0.48; p < 0.05). We are greatly concerned about these metabolic effects of CAPD; therefore, we should carefully select patients to be treated by CAPD. Aggressive nutritional and pharmacological treatment for glucose intolerance and hypercholesterolemia in CAPD patients must be performed in order to reduce the incidence of coronary artery disease (CAD).